Alpha-synuclein in the frontal brain and thinking problems in Lewy body dementias

Cortical Alpha-Synuclein in Dementia

NIH-funded research University of Iowa · NIH-11261178

This project looks at whether buildup of the protein alpha-synuclein in the frontal part of the brain disrupts circuits that cause problems with planning, attention, and flexible thinking in people with Lewy body dementias.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Iowa NIH-funded
Lab location1 site (Iowa City, United States)
Project IDNIH-11261178 on NIH RePORTER

What this research studies

From the patient's perspective, the research team is using lab models to add extra alpha-synuclein specifically to the prefrontal cortex and then watching individual brain cells with high-resolution two-photon imaging. They will track neuron activity and the tiny connections on neurons (dendritic spines) to see how these change when alpha-synuclein builds up. By focusing only on the frontal cortex, they aim to separate direct effects of the protein from changes caused by other brain systems. The goal is to learn how local protein aggregates could lead to the planning and attention problems seen in Lewy body dementias.

Who could benefit from this research

Good fit: This work is most relevant to people with Lewy body dementias — including Parkinson's disease dementia and dementia with Lewy bodies — especially those with troubles in planning, fluctuating attention, or flexible thinking.

Not a fit: People whose dementia is driven purely by Alzheimer-type pathology with no alpha-synuclein involvement, or those seeking immediate clinical treatments, are unlikely to get direct benefit from this preclinical work.

Why it matters

Potential benefit: If successful, this work could identify new circuit-level targets that lead to treatments to improve planning, attention, and flexible thinking in Lewy body dementia.

How similar studies have performed: Prior neuropathology and animal-model studies have linked alpha-synuclein to brain circuit problems, but directly imaging cortical neurons and spine plasticity in this focused way is relatively novel.

Where this research is happening

Iowa City, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.